CTOs on the Move

WHILL

www.whill.us

 
WHILL was started by a group of automotive, consumer electronics, and medical device designers and engineers who dreamed of pushing the boundaries of pedestrian transportation for everyone, especially for those who have difficulty walking.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

WHILL raised $45M on 09/17/2018

Similar Companies

Annex Ventures

Annex Ventures is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Eckert and Ziegler Isotope Products (EZIP)

Eckert and Ziegler Isotope Products (EZIP) is a Valencia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Carol Cole Company

Carol Cole Company is a Encinitas, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bardy Diagnostics

Bardy Diagnostics, Inc. (bardydx.com) has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM™) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM™ can be worn during exercise or while showering. Its unique, narrow, hourglass shape makes it especially advantageous for the female anatomy. Developed on the principle that non-invasive cardiac monitoring should provide an excellent quality atrial signal, the CAM is designed to be placed along the sternum—over the heart— to optimize P-wave signal capture. The result is improved ECG resolution, providing more information about the heart rhythm which may lead to more clinically actionable diagnoses.

RenalGuard Solutions

Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.